Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington’s disease.

Zesiewicz, TA, KL Sullivan, RA Hauser, and J Sanchez-Ramos. 2006. “Open-Label Pilot Study of Levetiracetam (Keppra) for the Treatment of Chorea in Huntington’s Disease.”. Mov Disord.

Last updated on 11/12/2024